House Of Lords Validates Angiotech's Stent Patent
The United Kingdom's House of Lords ruled Wednesday that Angiotech Pharmaceuticals Inc.'s patent for a drug-eluting stent is not invalid for obviousness, overturning decisions by two lower courts and ending a...To view the full article, register now.
Already a subscriber? Click here to view full article